A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder

NCT00969618 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

211

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG: Atomoxetine

Sponsor

Eli Lilly and Company